Navigation Links
ACS Infectious Diseases: Unique chemistry journal names editor
Date:7/10/2014

The American Chemical Society (ACS) announced today that Courtney Aldrich, Ph.D., will head the brand-new, web-only journal ACS Infectious Diseases as editor-in-chief. With the first issue slated for publication in January 2015, the pioneering journal will meet a growing demand for a place to publish top-notch chemistry-focused infectious diseases research.

"Our vision is to develop a journal focused on diseases with a strong emphasis on the basic science that advances the field and lays the foundation for the clinical sciences," says Editor-in-Chief Aldrich. He is an associate professor of medicinal chemistry at the University of Minnesota.

ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area an area that usually is served by journals with a biology focus. But with the journal's introduction, scientists like Aldrich, whose research focuses on discovering and developing new antibacterial agents for tuberculosis and multidrug resistant pathogens, will now have a high-quality chemistry journal in which they can publish their findings.

"Chemists have always played significant roles in infectious diseases starting with Louis Pasteur, who provided the first definitive evidence for the germ theory of diseases," says Aldrich. "Today, chemical tools are increasingly used to study the fundamental biology of infectious diseases, including pathogenesis, host immunity and drug resistance."

The time is right for a new journal that addresses this area of study. Infectious diseases are a major public health issue around the world. Every year, they are responsible for about one-third of all deaths roughly 3.5 million people according to the World Health Organization. Globally, over half a million people died from malaria, and about 1 million people died from tuberculosis in 2012. In the U.S., HIV, pneumonia and influenza are among the leading causes of infectious diseases deaths. New diseases are emerging, and those thought to be under control are re-emerging. Microbial resistance to known drugs is increasing, leaving physicians with few or no choices for treating many patients.

"ACS Infectious Diseases will further broaden the scientific depth and breadth of ACS journals by providing an important publishing outlet for chemists and affiliated scientists working in this vitally important area," says Susan King, Ph.D., senior vice president of the ACS Journals Publishing Group. "We look forward to working with Dr. Aldrich to make the new journal a success."

Key research areas for the monthly journal include:

  • Chemistry and bioactivity of antivirals, antibiotics and antiprotozoal agents
  • Mechanisms of action and drug resistance
  • Host-pathogen interactions
  • Characterization and validation of drug targets
  • Small-molecule antiviral adjuvants for vaccines

Manuscript submission will open in September.


'/>"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Related biology news :

1. Environmental concerns increasing infectious disease in amphibians, other animals
2. First antibiotic stewardship probed in the Journal of the Pediatric Infectious Diseases Society
3. Call for global monitoring of infectious diseases in dogs and cats
4. Unique peptide could treat cancers, neurological disorders, and infectious diseases
5. International space station plays host to innovative infectious disease research
6. Pressurized virus blasts its infectious DNA into human cells
7. Study explores the role of uncertainty in infectious disease modelling
8. Old drug may teach new tricks in treating infectious diseases, cancer
9. College of Veterinary Medicine researcher doubles down on deadly, infectious cat diseases
10. Study to identify functions of hypothetical genes in 2 infectious disease pathogens
11. Shrink wrap used to enhance detection of infectious disease biomarkers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... Systems, Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & ... intelligence provider visiongain offers comprehensive analysis of ... that this market will generate revenues of $17.98 billion ... Systems acquired DVTEL Inc, a leader in software and ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... , December 5, 2016 ... "Cell Expansion Market, by Products (Consumable, Instruments, Automated ... (Regenerative Medicine and Stem Cell Research, Cancer, and ... Institutes, Cell Banks) - Global Revenue, Trends, Growth, ... Scalar Market Research, the global cell expansion market ...
(Date:12/5/2016)... 2016 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or the ... and Safety Monitoring Board (DSMB) for the Company,s ... (CVD) patients has completed a second planned safety ... as planned without any modifications. The DSMB reviewed ... or efficacy concerns were identified. The DSMB will ...
(Date:12/5/2016)... Dec. 5, 2016  Eisai Inc. announced today ... study of rufinamide, which were presented at the ... (AES) held from December 2-6 in ... safety, tolerability and cognitive data showed that patients ... safety and tolerability profiles, cognitive development and behavior, ...
(Date:12/5/2016)... 5, 2016 The U.S. Biotechnology ... $108 billion of revenue and some $890 billion of ... on global biopharmaceuticals, and this figure is expected to ... lined up these four equities for assessment: Northwest Biotherapeutics ... (NASDAQ: ACAD ), Acorda Therapeutics Inc. (NASDAQ: ...
Breaking Biology Technology: